Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Valsartan

An angiotensin II receptor blocker (sartan) that relaxes blood vessels: patented in 1990 and in use since 1996 for high blood pressure, heart failure and after a heart attack. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?An amino acid hides in its molecule, valine: industrial synthesis starts from L-valine, onto which the biphenyl backbone typical of sartans is attached.

ValsartanGo to the active ingredient →
ValsartanActive ingredientValsartanCat. No. P-V014-001CAS 137862-53-4
Valsartan-d3Isotopically labelledValsartan-d3Cat. No. P-V014-010CAS 1331908-02-1

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceValsartan CRSEDQM code Y0001132Family Valsartan

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.